Thursday, April 16, 2015
Vargatef (nintedanib) in combination with docetaxel accepted for use within NHS Scotland
Boehringer Ingelheim Limited are delighted that the Scottish Medicines Consortium (SMC), following a full submission under the end of life and orphan equivalent process has accepted nintedanib...Vargatef (nintedanib) in combination with docetaxel accepted for use within NHS Scotland
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.